These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18275418)

  • 1. A systematic review of curricula on relationships between residents and the pharmaceutical industry.
    Montague BT; Fortin AH; Rosenbaum J
    Med Educ; 2008 Mar; 42(3):301-8. PubMed ID: 18275418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conflicts of Interest in Medicine. A Systematic Review of Published and Scientifically evaluated Curricula.
    Weißkircher J; Koch C; Dreimüller N; Lieb K
    GMS J Med Educ; 2017; 34(3):Doc37. PubMed ID: 28890928
    [No Abstract]   [Full Text] [Related]  

  • 3. Interactions between pharmaceutical representatives and doctors in training. A thematic review.
    Zipkin DA; Steinman MA
    J Gen Intern Med; 2005 Aug; 20(8):777-86. PubMed ID: 16050893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residency Curricula on Physician-Pharmaceutical Industry Interaction: A CERA Study.
    Evans DV; Waters RC; Olsen C; Stephens MB; Brown SR
    Fam Med; 2016 Jan; 48(1):44-8. PubMed ID: 26950665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To what extent do educational interventions impact medical trainees' attitudes and behaviors regarding industry-trainee and industry-physician relationships?
    Carroll AE; Vreeman RC; Buddenbaum J; Inui TS
    Pediatrics; 2007 Dec; 120(6):e1528-35. PubMed ID: 18055668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What residents don't know about physician-pharmaceutical industry interactions.
    Watkins RS; Kimberly J
    Acad Med; 2004 May; 79(5):432-7. PubMed ID: 15107282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structured pharmaceutical representative interactions and counterdetailing sessions as components of medical resident education.
    Wall GC; Smith HL; Craig SR; Yost WJ
    J Pharm Pract; 2013 Apr; 26(2):151-6. PubMed ID: 23340914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks.
    Hodges B
    CMAJ; 1995 Sep; 153(5):553-9. PubMed ID: 7641153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of an educational intervention on residents' knowledge and attitudes toward interactions with pharmaceutical representatives.
    Hopper JA; Speece MW; Musial JL
    J Gen Intern Med; 1997 Oct; 12(10):639-42. PubMed ID: 9346461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between physicians and the pharmaceutical industry: what does the literature say?
    Lexchin J
    CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of resident research curricula.
    Hebert RS; Levine RB; Smith CG; Wright SM
    Acad Med; 2003 Jan; 78(1):61-8. PubMed ID: 12525411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of marketing interactions with medical trainees' knowledge about evidence-based prescribing: results from a national survey.
    Austad KE; Avorn J; Franklin JM; Campbell EG; Kesselheim AS
    JAMA Intern Med; 2014 Aug; 174(8):1283-90. PubMed ID: 24911123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric resident and faculty views on and interactions with the pharmaceutical industry.
    Misra S; Ganzini L; Keepers G
    Acad Psychiatry; 2010; 34(2):102-8. PubMed ID: 20224017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Attitudes and behaviors of psychiatry residents and psychiatrists working in training institutes towards the relationship between the pharmaceutical industry and physicians].
    Gülöksüz S; Oral ET; Ulaş H
    Turk Psikiyatri Derg; 2009; 20(3):236-42. PubMed ID: 19757223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teaching information mastery: evaluating information provided by pharmaceutical representatives.
    Shaughnessy AF; Slawson DC; Bennett JH
    Fam Med; 1995 Oct; 27(9):581-5. PubMed ID: 8829983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dangerous liaisons: doctors-in-training and the pharmaceutical industry.
    Pokorny AM; Gittins CB
    Intern Med J; 2015 Oct; 45(10):1085-8. PubMed ID: 26429220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using the literature in developing McGill's guidelines for interactions between residents and the pharmaceutical industry.
    Wazana A; Granich A; Primeau F; Bhanji NH; Jalbert M
    Acad Med; 2004 Nov; 79(11):1033-40. PubMed ID: 15504767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A statewide screening, brief intervention, and referral to treatment (SBIRT) curriculum for medical residents: Differential implementation strategies in heterogeneous medical residency programs.
    Pringle JL; Kearney SM; Rickard-Aasen S; Campopiano MM; Gordon AJ
    Subst Abus; 2017; 38(2):161-167. PubMed ID: 28332942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposed guidelines for housestaff interaction with pharmaceutical companies.
    Forrest DM; Ruedy J
    Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacy residents' attitudes toward pharmaceutical industry promotion.
    Ashker S; Burkiewicz JS
    Am J Health Syst Pharm; 2007 Aug; 64(16):1724-31. PubMed ID: 17687062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.